Clorox (CLX) Financials

$130.17 -0.19 (-0.15%)

Closing price 03:59 PM Eastern

Extended Trading

$129.82 -0.35 (-0.27%)

As of 06:34 PM Eastern

Annual Income Statements for Clorox

This table shows Clorox's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020	6/30/2019	6/30/2018	6/30/2017	6/30/2016	6/30/2015
Net Income / (Loss) Attributable to Common Shareholders	280	149	462	710	939	820	823	701	648	5,629
Consolidated Net Income / (Loss)	292	161	471	719	939	820	823	701	648	580
Net Income / (Loss) Continuing Operations	292	161	471	719	939	820	823	703	648	606
Total Pre-Tax Income	398	238	607	900	1,185	1,024	1,054	1,033	983	0.00
Total Operating Income	683	408	750	927	1,274	1,124	1,136	1,127	1,064	5,655
Total Gross Profit	3,048	2,908	2,545	3,199	3,063	2,728	2,675	2,671	2,598	2,465
Total Revenue	7,093	7,389	7,107	7,341	6,721	6,214	6,124	5,973	5,761	5,655
Operating Revenue	7,093	7,389	7,107	7,341	6,721	6,214	6,124	5,973	5,761	5,655
Total Cost of Revenue	4,045	4,481	4,562	4,142	3,658	3,486	3,449	3,302	3,163	0.00
Operating Cost of Revenue	4,045	4,481	4,562	4,142	3,658	3,486	3,449	3,302	3,163	0.00
Total Operating Expenses	2,365	2,500	1,795	2,272	1,789	1,604	1,539	1,544	1,534	0.00
Selling, General & Admin Expense	1,167	1,183	954	1,004	969	856	837	810	806	0.00
Marketing Expense	832	734	709	790	675	612	570	599	587	0.00
Research & Development Expense	126	138	132	149	145	136	132	135	141	0.00
Impairment Charge	0.00	445	0.00	329	0.00	0.00	-	-	-	-
Other Special Charges / (Income)	240	0.00	0.00	-	-	-	-	-	-	-
Total Other Income / (Expense), net	-285	-170	-143	-27	-89	-100	-82	-94	-81	0.00
Interest Expense	90	90	106	99	99	97	85	88	88	0.00
Other Income / (Expense), net	-195	-80	-37	72	10	-3.00	3.00	-6.00	7.00	0.00
Income Tax Expense	106	77	136	181	246	204	231	330	335	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	12	12	9.00	9.00	0.00	0.00	-	-	-	-
Basic Earnings per Share	$2.26	$1.21	$3.75	$5.66	$7.46	$6.42	$6.37	$5.43	$5.01	$0.00
Weighted Average Basic Shares Outstanding	124.17M	123.59M	123.11M	125.57M	125.83M	127.73M	129.29M	128.95M	129.47M	0.00
Diluted Earnings per Share	$2.25	$1.20	$3.73	$5.58	$7.36	$6.32	$6.26	$5.33	$4.92	$0.00
Weighted Average Diluted Shares Outstanding	124.80M	124.18M	123.91M	127.30M	127.67M	129.79M	131.58M	131.57M	131.72M	0.00
Weighted Average Basic & Diluted Shares Outstanding	123.86M	123.83M	123.16M	122.81M	126.21M	127.70M	129.20M	129.10M	129.30M	130.30M
Cash Dividends to Common per Share	$4.80	$4.72	$4.64	$4.44	$4.24	$3.84	$3.48	$3.20	$3.08	$2.99

This table shows Clorox's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	186	193	99	216	-51	93	22	176	-211	99	85
Consolidated Net Income / (Loss)	191	194	103	221	-50	96	25	181	-209	102	87
Net Income / (Loss) Continuing Operations	191	194	103	221	-50	96	25	181	-209	102	87
Total Pre-Tax Income	254	237	177	275	-42	136	29	237	-245	130	116
Total Operating Income	243	236	176	317	-22	326	62	284	-197	149	172
Total Gross Profit	744	738	807	884	766	866	532	862	800	620	626
Total Revenue	1,668	1,686	1,762	1,903	1,814	1,990	1,386	2,019	1,915	1,715	1,740
Operating Revenue	1,668	1,686	1,762	1,903	1,814	1,990	1,386	2,019	1,915	1,715	1,740
Total Cost of Revenue	924	948	955	1,019	1,048	1,124	854	1,157	1,115	1,095	1,114
Operating Cost of Revenue	924	948	955	1,019	1,048	1,124	854	1,157	1,115	1,095	1,114
Total Operating Expenses	501	502	631	567	788	540	470	578	997	471	454
Selling, General & Admin Expense	267	280	281	268	301	322	276	329	311	282	261
Marketing Expense	207	191	201	266	215	186	165	211	206	156	161
Research & Development Expense	27	31	31	33	32	32	29	38	35	33	32
Other Special Charges / (Income)	0.00	0.00	118	-	240	0.00	0.00	-	0.00	-	-
Total Other Income / (Expense), net	11	1.00	1.00	-42	-20	-190	-33	-47	-48	-19	-56
Interest Expense	23	22	21	21	22	26	21	21	24	23	22
Other Income / (Expense), net	34	23	22	-21	2.00	-164	-12	-26	-24	4.00	-34
Income Tax Expense	63	43	74	54	8.00	40	4.00	56	-36	28	29
Net Income / (Loss) Attributable to Noncontrolling Interest	5.00	1.00	4.00	5.00	1.00	3.00	3.00	5.00	2.00	3.00	2.00
Basic Earnings per Share	$1.51	$1.55	$0.80	$1.75	($0.41)	$0.75	$0.17	$1.42	($1.71)	$0.81	$0.69
Weighted Average Basic Shares Outstanding	123.37M	123.77M	123.80M	124.17M	124.25M	124.18M	123.97M	123.59M	123.65M	123.55M	123.34M
Diluted Earnings per Share	$1.50	$1.54	$0.80	$1.74	($0.41)	$0.75	$0.17	$1.43	($1.71)	$0.80	$0.68
Weighted Average Diluted Shares Outstanding	124.07M	124.66M	124.68M	124.80M	124.25M	124.62M	124.65M	124.18M	123.65M	123.99M	123.91M
Weighted Average Basic & Diluted Shares Outstanding	123.25M	123.19M	123.78M	123.86M	124.19M	124.11M	124.06M	123.83M	123.62M	123.52M	123.38M
Cash Dividends to Common per Share	$1.22	$1.22	$2.44	-	$1.20	$1.20	$2.40	-	$1.18	$1.18	$2.36

This table details how cash moves in and out of Clorox's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020	6/30/2019	6/30/2018	6/30/2017	6/30/2016	6/30/2015
Net Change in Cash & Equivalents	-161	182	-138	-555	766	-21	-285	14	19	53
Net Cash From Operating Activities	695	1,158	786	1,276	1,546	992	976	865	778	874
Net Cash From Continuing Operating Activities	695	1,158	786	1,276	1,546	992	976	868	768	858
Net Income / (Loss) Continuing Operations	292	161	471	719	939	820	823	703	648	606
Consolidated Net Income / (Loss)	292	161	471	719	939	820	823	701	648	580
Depreciation Expense	235	236	224	211	180	180	166	163	165	169
Non-Cash Adjustments To Reconcile Net Income	509	557	184	387	99	14	97	84	46	-10
Changes in Operating Assets and Liabilities, net	-341	204	-93	-41	328	-22	-110	-82	-91	93
Net Cash From Investing Activities	-175	-223	-229	-452	-252	-196	-859	-205	-430	-106
Net Cash From Continuing Investing Activities	-175	-223	-229	-452	-252	-196	-859	-205	-430	-106
Purchase of Property, Plant & Equipment	-212	-228	-251	-331	-254	-206	-194	-231	-172	-125
Divestitures	17	0.00	0.00	-	-	-	-	-	-	-
Other Investing Activities, net	20	5.00	22	-36	2.00	10	16	26	32	19
Net Cash From Financing Activities	-655	-753	-689	-1,391	-523	-815	-399	-645	-316	-696
Net Cash From Continuing Financing Activities	-655	-753	-689	-1,391	-523	-815	-399	-645	-316	-696
Repayment of Debt	0.00	0.00	-1,405	0.00	0.00	-	-614	-125	-300	-623
Repurchase of Common Equity	0.00	0.00	-25	-905	-248	-661	-271	-183	-254	-434
Payment of Dividends	-611	-598	-586	-589	-533	-490	-450	-412	-398	-385
Issuance of Debt	-45	-188	1,322	0.00	96	189	891	0.00	426	495
Issuance of Common Equity	1.00	33	5.00	103	162	147	45	75	210	-
Effect of Exchange Rate Changes	-26	0.00	-6.00	12	-5.00	-2.00	-3.00	-1.00	-13	-19
Cash Interest Paid	102	99	89	89	89	87	75	78	79	104
Cash Income Taxes Paid	347	73	100	303	241	207	245	347	323	236

This table details how cash moves in and out of Clorox's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-65	12	75	-14	-137	-162	152	122	76	-110	94
Net Cash From Operating Activities	286	180	221	340	182	153	20	430	341	209	178
Net Cash From Continuing Operating Activities	286	180	221	340	182	153	20	430	341	209	178
Net Income / (Loss) Continuing Operations	191	194	103	221	-50	96	25	181	-209	102	87
Consolidated Net Income / (Loss)	191	194	103	221	-50	96	25	181	-209	102	87
Depreciation Expense	55	53	54	59	58	57	61	62	60	58	56
Non-Cash Adjustments To Reconcile Net Income	10	37	120	27	274	194	14	18	471	41	27
Changes in Operating Assets and Liabilities, net	30	-104	-56	33	-100	-194	-80	169	19	8.00	8.00
Net Cash From Investing Activities	-53	-54	89	-81	-38	-33	-23	-81	-55	-42	-45
Net Cash From Continuing Investing Activities	-53	-54	89	-81	-38	-33	-23	-81	-55	-42	-45
Purchase of Property, Plant & Equipment	-53	-53	-39	-81	-55	-52	-24	-84	-56	-42	-46
Net Cash From Financing Activities	-299	-109	-237	-273	-278	-259	155	-227	-211	-280	-35
Net Cash From Continuing Financing Activities	-299	-109	-237	-273	-278	-259	155	-227	-211	-280	-35
Repayment of Debt	-134	-	-	-	-	-103	298	99	-71	-	-
Payment of Dividends	-166	-151	-151	-165	-148	-149	-149	-161	-146	-146	-145
Issuance of Common Equity	1.00	8.00	21	-2.00	4.00	-7.00	6.00	23	6.00	5.00	-1.00
Effect of Exchange Rate Changes	1.00	-5.00	2.00	-	-3.00	-23	0.00	-	1.00	3.00	-4.00

This table presents Clorox's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020	6/30/2019	6/30/2018	6/30/2017	6/30/2016	6/30/2015
Total Assets	5,751	5,945	6,158	6,334	6,213	5,116	5,060	4,573	4,510	4,164
Total Current Assets	1,622	1,828	1,725	1,829	2,020	1,305	1,311	1,514	1,485	1,429
Cash & Equivalents	202	367	183	319	871	111	131	418	401	382
Accounts Receivable	695	688	681	604	648	631	600	565	569	519
Inventories, net	637	696	755	752	454	512	506	459	443	385
Prepaid Expenses	88	77	106	154	47	51	74	72	72	-
Plant, Property, & Equipment, net	1,315	1,345	1,334	1,302	1,103	1,034	996	931	906	918
Total Noncurrent Assets	2,814	2,772	3,099	3,203	3,090	2,777	2,753	2,128	2,119	1,817
Goodwill	1,228	1,252	1,558	1,575	1,577	1,591	1,602	1,196	1,197	1,067
Intangible Assets	681	712	884	918	894	912	929	722	735	585
Other Noncurrent Operating Assets	905	808	657	710	619	274	222	210	187	165
Total Liabilities & Shareholders' Equity	5,751	5,945	6,158	6,334	6,213	5,116	5,060	4,573	4,510	4,164
Total Liabilities	5,259	5,557	5,429	5,742	5,305	4,557	4,334	4,031	4,213	4,046
Total Current Liabilities	1,574	1,917	1,784	2,056	1,418	1,440	1,200	1,809	1,558	1,405
Short-Term Debt	4.00	50	237	300	0.00	396	199	804	523	395
Accounts Payable	1,486	1,659	1,469	1,675	1,329	1,035	1,001	1,005	1,035	979
Other Current Liabilities	84	87	78	81	64	0.00	-	-	-	-
Total Noncurrent Liabilities	3,685	3,640	3,645	3,686	3,887	3,117	3,134	2,222	2,655	2,641
Long-Term Debt	2,481	2,477	2,474	2,484	2,780	2,287	3,062	2,161	2,573	2,546
Noncurrent Deferred & Payable Income Tax Liabilities	22	28	66	67	62	50	72	61	82	95
Other Noncurrent Operating Liabilities	1,182	1,135	1,105	1,135	1,045	780	-	-	-	-
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	492	388	729	592	908	559	726	542	297	118
Total Preferred & Common Equity	328	220	556	411	908	559	726	542	297	118
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	328	220	556	411	908	559	726	542	297	118
Common Stock	1,419	1,376	1,333	1,317	1,296	1,205	1,134	1,087	1,027	934
Retained Earnings	250	583	1,048	1,036	3,567	3,150	2,797	2,440	2,163	1,923
Treasury Stock	-1,186	-1,246	-1,346	-1,396	-3,315	-3,194	-2,658	-2,442	-2,323	-2,237
Accumulated Other Comprehensive Income / (Loss)	-155	-493	-479	-546	-640	-602	-547	-543	-570	-502
Noncontrolling Interest	164	168	173	181	0.00	-	-	-	-	-

This table presents Clorox's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	5,512	5,577	5,497	5,751	5,805	5,908	5,991	5,945	5,818	6,045	6,153
Total Current Assets	1,590	1,632	1,576	1,622	1,661	1,804	1,911	1,828	1,745	1,622	1,763
Cash & Equivalents	226	290	278	202	219	355	518	367	242	168	278
Accounts Receivable	597	603	595	695	673	679	581	688	678	600	612
Inventories, net	635	592	594	637	674	655	710	696	735	741	755
Prepaid Expenses	132	147	109	88	95	115	102	77	90	113	118
Plant, Property, & Equipment, net	1,245	1,242	1,242	1,315	1,292	1,314	1,317	1,345	1,315	1,322	1,322
Total Noncurrent Assets	2,677	2,703	2,679	2,814	2,852	2,790	2,763	2,772	2,758	3,101	3,068
Goodwill	1,222	1,219	1,233	1,228	1,229	1,252	1,246	1,252	1,250	1,553	1,546
Intangible Assets	569	574	581	681	688	698	703	712	722	868	875
Other Noncurrent Operating Assets	886	910	865	905	935	840	814	808	786	680	647
Total Liabilities & Shareholders' Equity	5,512	5,577	5,497	5,751	5,805	5,908	5,991	5,945	5,818	6,045	6,153
Total Liabilities	5,322	5,456	5,273	5,259	5,550	5,690	5,860	5,557	5,646	5,554	5,657
Total Current Liabilities	2,155	1,730	1,579	1,574	1,846	2,022	2,228	1,917	1,996	1,878	2,010
Short-Term Debt	54	189	4.00	4.00	111	247	347	50	138	209	348
Accounts Payable	2,016	1,460	1,472	1,486	1,653	1,649	1,678	1,659	1,722	1,589	1,584
Other Current Liabilities	85	81	83	84	82	92	88	87	88	80	78
Total Noncurrent Liabilities	3,167	3,726	3,694	3,685	3,704	3,668	3,632	3,640	3,650	3,676	3,647
Long-Term Debt	2,483	2,483	2,482	2,481	2,480	2,479	2,478	2,477	2,476	2,476	2,475
Noncurrent Deferred & Payable Income Tax Liabilities	21	22	23	22	24	26	27	28	27	56	59
Other Noncurrent Operating Liabilities	663	1,221	1,189	1,182	1,200	1,163	1,127	1,135	1,147	1,144	1,113
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	190	121	224	492	255	218	131	388	172	491	496
Total Preferred & Common Equity	27	-41	60	328	91	53	-37	220	3.00	321	326
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	27	-41	60	328	91	53	-37	220	3.00	321	326
Common Stock	1,435	1,418	1,428	1,419	1,401	1,376	1,377	1,376	1,363	1,338	1,324
Retained Earnings	99	68	31	250	34	241	299	583	415	782	832
Treasury Stock	-1,331	-1,346	-1,252	-1,186	-1,189	-1,205	-1,219	-1,246	-1,277	-1,297	-1,315
Accumulated Other Comprehensive Income / (Loss)	-176	-181	-147	-155	-155	-359	-494	-493	-498	-502	-515
Noncontrolling Interest	163	162	164	164	164	165	168	168	169	170	170

This table displays calculated financial ratios and metrics derived from Clorox's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020	6/30/2019	6/30/2018	6/30/2017	6/30/2016	6/30/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-4.01%	3.97%	-3.19%	9.22%	8.16%	1.47%	2.53%	3.68%	1.87%	2.56%
EBITDA Growth	28.19%	-39.81%	-22.56%	-17.35%	12.53%	-0.31%	1.64%	3.88%	-78.78%	2.34%
EBIT Growth	48.78%	-54.00%	-28.63%	-22.20%	14.54%	-1.58%	1.61%	4.67%	-81.06%	2.56%
NOPAT Growth	81.56%	-52.57%	-21.42%	-26.64%	12.16%	1.47%	15.65%	9.35%	-82.28%	2.56%
Net Income Growth	81.37%	-65.82%	-34.49%	-23.43%	14.51%	-0.36%	17.40%	8.18%	11.72%	3.94%
EPS Growth	87.50%	-67.83%	-33.15%	-24.18%	16.46%	0.96%	17.45%	8.33%	0.00%	0.00%
Operating Cash Flow Growth	-39.98%	47.33%	-38.40%	-17.46%	55.85%	1.64%	12.83%	11.18%	-10.98%	13.95%
Free Cash Flow Firm Growth	-72.17%	157.88%	-23.69%	-62.18%	-18.56%	1,253.91%	-82.08%	73.39%	-88.70%	-13.23%
Invested Capital Growth	8.91%	-21.77%	6.54%	8.52%	-10.03%	-18.80%	24.83%	3.24%	11.77%	25.21%
Revenue Q/Q Growth	-1.61%	3.04%	-0.01%	-2.41%	5.59%	-1.02%	0.72%	0.79%	0.75%	1.07%
EBITDA Q/Q Growth	5.09%	20.77%	4.81%	-19.17%	7.57%	-0.84%	1.24%	3.46%	-79.09%	2.21%
EBIT Q/Q Growth	8.44%	38.98%	5.94%	-22.74%	8.72%	-1.15%	1.15%	4.09%	-81.36%	2.33%
NOPAT Q/Q Growth	10.13%	39.13%	2.20%	-19.47%	5.33%	2.51%	1.87%	6.15%	-81.69%	-12.45%
Net Income Q/Q Growth	15.87%	91.67%	0.86%	-22.61%	7.93%	3.02%	1.98%	5.41%	-3.86%	3.76%
EPS Q/Q Growth	15.98%	103.39%	0.00%	-22.28%	8.24%	3.27%	2.29%	5.34%	564.86%	100.00%
Operating Cash Flow Q/Q Growth	-11.47%	8.94%	-5.76%	-21.86%	29.37%	-1.10%	1.77%	6.40%	-5.81%	5.05%
Free Cash Flow Firm Q/Q Growth	-26.32%	13.04%	-34.31%	-38.63%	-27.18%	755.06%	-84.53%	265.22%	-89.96%	-27.00%
Invested Capital Q/Q Growth	5.63%	0.16%	1.24%	-5.33%	-9.86%	-21.41%	16.99%	-3.50%	44.33%	28.09%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	42.97%	39.36%	35.81%	43.58%	45.57%	43.90%	43.68%	44.72%	45.10%	43.59%
EBITDA Margin	10.19%	7.63%	13.18%	16.48%	21.78%	20.94%	21.31%	21.50%	21.45%	102.99%
Operating Margin	9.63%	5.52%	10.55%	12.63%	18.96%	18.09%	18.55%	18.87%	18.47%	100.00%
EBIT Margin	6.88%	4.44%	10.03%	13.61%	19.10%	18.04%	18.60%	18.77%	18.59%	100.00%
Profit (Net Income) Margin	4.12%	2.18%	6.63%	9.79%	13.97%	13.20%	13.44%	11.74%	11.25%	10.26%
Tax Burden Percent	73.37%	67.65%	77.59%	79.89%	79.24%	80.08%	78.08%	67.86%	65.92%	0.00%
Interest Burden Percent	81.56%	72.56%	85.13%	90.09%	92.29%	91.35%	92.54%	92.15%	91.78%	0.00%
Effective Tax Rate	26.63%	32.35%	22.41%	20.11%	20.76%	19.92%	21.92%	31.95%	34.08%	0.00%
Return on Invested Capital (ROIC)	18.83%	9.51%	18.43%	25.22%	33.95%	25.76%	25.54%	25.23%	24.75%	164.42%
ROIC Less NNEP Spread (ROIC-NNEP)	9.42%	4.60%	13.99%	24.23%	30.80%	22.96%	23.29%	22.71%	22.71%	15.69%
Return on Net Nonoperating Assets (RNNOA)	47.54%	19.32%	52.88%	70.65%	94.07%	101.86%	104.27%	141.88%	287.54%	262.05%
Return on Equity (ROE)	66.36%	28.83%	71.31%	95.87%	128.02%	127.63%	129.81%	167.10%	312.29%	426.47%
Cash Return on Invested Capital (CROIC)	10.30%	33.94%	12.10%	17.04%	44.50%	46.52%	3.46%	22.03%	13.63%	142.04%
Operating Return on Assets (OROA)	8.34%	5.42%	11.42%	15.92%	22.67%	22.03%	23.65%	24.68%	24.69%	134.29%
Return on Assets (ROA)	4.99%	2.66%	7.54%	11.46%	16.58%	16.12%	17.09%	15.44%	14.94%	13.77%
Return on Common Equity (ROCE)	41.33%	20.03%	52.20%	84.30%	128.02%	127.63%	129.81%	167.10%	312.29%	426.47%
Return on Equity Simple (ROE_SIMPLE)	89.02%	73.18%	84.71%	174.94%	103.41%	146.69%	113.36%	129.34%	218.18%	491.53%
Net Operating Profit after Tax (NOPAT)	501	276	582	741	1,010	900	887	767	701	3,959
NOPAT Margin	7.06%	3.74%	8.19%	10.09%	15.02%	14.48%	14.48%	12.84%	12.17%	70.00%
Net Nonoperating Expense Percent (NNEP)	9.41%	4.91%	4.44%	0.99%	3.15%	2.81%	2.26%	2.52%	2.03%	148.73%
Cost of Revenue to Revenue	57.03%	60.64%	64.19%	56.42%	54.43%	56.10%	56.32%	55.28%	54.90%	0.00%
SG&A Expenses to Revenue	16.45%	16.01%	13.42%	13.68%	14.42%	13.78%	13.67%	13.56%	13.99%	0.00%
R&D to Revenue	1.78%	1.87%	1.86%	2.03%	2.16%	2.19%	2.16%	2.26%	2.45%	0.00%
Operating Expenses to Revenue	33.34%	33.83%	25.26%	30.95%	26.62%	25.81%	25.13%	25.85%	26.63%	0.00%
Earnings before Interest and Taxes (EBIT)	488	328	713	999	1,284	1,121	1,139	1,121	1,071	5,655
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	723	564	937	1,210	1,464	1,301	1,305	1,284	1,236	5,824
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	51.23	85.65	28.97	49.15	26.89	30.06	20.25	25.86	48.01	89.80
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.37	2.55	2.27	2.75	3.63	2.70	2.40	2.35	2.47	1.87
Price to Earnings (P/E)	60.01	126.46	34.86	28.45	26.01	20.49	17.86	20.00	22.00	1.88
Dividend Yield	3.55%	3.10%	3.55%	2.73%	2.19%	2.91%	3.07%	2.94%	2.79%	3.66%
Earnings Yield	1.67%	0.79%	2.87%	3.51%	3.85%	4.88%	5.60%	5.00%	4.54%	53.12%
Enterprise Value to Invested Capital (EV/IC)	6.94	8.31	5.77	7.47	9.35	6.19	4.62	5.36	5.67	4.91
Enterprise Value to Revenue (EV/Rev)	2.71	2.87	2.65	3.11	3.92	3.12	2.91	2.77	2.94	2.33
Enterprise Value to EBITDA (EV/EBITDA)	26.63	37.54	20.07	18.88	17.98	14.89	13.67	12.90	13.72	2.26
Enterprise Value to EBIT (EV/EBIT)	39.45	64.54	26.38	22.87	20.51	17.28	15.66	14.78	15.83	2.33
Enterprise Value to NOPAT (EV/NOPAT)	38.42	76.71	32.32	30.85	26.08	21.52	20.10	21.60	24.17	3.32
Enterprise Value to Operating Cash Flow (EV/OCF)	27.70	18.28	23.93	17.91	17.03	19.53	18.27	19.15	21.79	15.05
Enterprise Value to Free Cash Flow (EV/FCFF)	70.23	21.49	49.24	45.64	19.89	11.92	148.57	24.73	43.87	3.85
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	5.05	6.51	3.72	4.70	3.06	4.80	4.49	5.47	10.42	24.92
Long-Term Debt to Equity	5.04	6.38	3.39	4.20	3.06	4.09	4.22	3.99	8.66	21.58
Financial Leverage	5.05	4.20	3.78	2.92	3.05	4.44	4.48	6.25	12.66	16.70
Leverage Ratio	13.29	10.84	9.46	8.36	7.72	7.92	7.60	10.83	20.90	30.96
Compound Leverage Factor	10.84	7.86	8.05	7.54	7.13	7.23	7.03	9.98	19.18	0.00
Debt to Total Capital	83.47%	86.69%	78.81%	82.46%	75.38%	82.76%	81.79%	84.55%	91.25%	96.14%
Short-Term Debt to Total Capital	0.13%	1.72%	6.89%	8.89%	0.00%	12.21%	4.99%	22.93%	15.41%	12.91%
Long-Term Debt to Total Capital	83.34%	84.97%	71.92%	73.58%	75.38%	70.54%	76.80%	61.62%	75.83%	83.23%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	5.51%	5.76%	5.03%	5.36%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	11.02%	7.55%	16.16%	12.17%	24.62%	17.24%	18.21%	15.45%	8.75%	3.86%
Debt to EBITDA	3.44	4.48	2.89	2.30	1.90	2.06	2.50	2.31	2.50	0.51
Net Debt to EBITDA	3.16	3.83	2.70	2.04	1.30	1.98	2.40	1.98	2.18	0.44
Long-Term Debt to EBITDA	3.43	4.39	2.64	2.05	1.90	1.76	2.35	1.68	2.08	0.44
Debt to NOPAT	4.96	9.16	4.66	3.76	2.75	2.98	3.68	3.87	4.41	0.74
Net Debt to NOPAT	4.56	7.83	4.34	3.33	1.89	2.86	3.53	3.32	3.84	0.65
Long-Term Debt to NOPAT	4.95	8.97	4.25	3.35	2.75	2.54	3.45	2.82	3.67	0.64
Altman Z-Score	3.50	3.58	3.54	3.98	5.45	4.98	4.79	4.87	4.74	8.06
Noncontrolling Interest Sharing Ratio	37.73%	30.53%	26.80%	12.07%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.03	0.95	0.97	0.89	1.42	0.91	1.09	0.84	0.95	1.02
Quick Ratio	0.57	0.55	0.48	0.45	1.07	0.52	0.61	0.54	0.62	0.64
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	274	985	382	501	1,324	1,625	120	670	386	3,420
Operating Cash Flow to CapEx	327.83%	507.89%	313.15%	385.50%	608.66%	481.55%	503.09%	374.46%	452.33%	699.20%
Free Cash Flow to Firm to Interest Expense	3.05	10.94	3.60	5.06	13.37	16.75	1.41	7.61	4.39	0.00
Operating Cash Flow to Interest Expense	7.72	12.87	7.42	12.89	15.62	10.23	11.48	9.83	8.84	0.00
Operating Cash Flow Less CapEx to Interest Expense	5.37	10.33	5.05	9.55	13.05	8.10	9.20	7.20	6.89	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.21	1.22	1.14	1.17	1.19	1.22	1.27	1.32	1.33	1.34
Accounts Receivable Turnover	10.26	10.79	11.06	11.73	10.51	10.10	10.51	10.53	10.59	10.62
Inventory Turnover	6.07	6.18	6.05	6.87	7.57	6.85	7.15	7.32	7.64	0.00
Fixed Asset Turnover	5.33	5.52	5.39	6.10	6.29	6.12	6.36	6.50	6.32	5.97
Accounts Payable Turnover	2.57	2.87	2.90	2.76	3.09	3.42	3.44	3.24	3.14	0.00
Days Sales Outstanding (DSO)	35.58	33.81	33.00	31.13	34.73	36.15	34.72	34.65	34.47	34.37
Days Inventory Outstanding (DIO)	60.14	59.10	60.29	53.14	48.19	53.29	51.06	49.85	47.77	0.00
Days Payable Outstanding (DPO)	141.89	127.40	125.77	132.36	117.94	106.59	106.15	112.75	116.20	0.00
Cash Conversion Cycle (CCC)	-46.17	-34.49	-32.49	-48.10	-35.02	-17.14	-20.37	-28.25	-33.96	34.37
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,775	2,548	3,257	3,057	2,817	3,131	3,856	3,089	2,992	2,677
Invested Capital Turnover	2.67	2.55	2.25	2.50	2.26	1.78	1.76	1.96	2.03	2.35
Increase / (Decrease) in Invested Capital	227	-709	200	240	-314	-725	767	97	315	539
Enterprise Value (EV)	19,251	21,171	18,806	22,847	26,329	19,373	17,833	16,566	16,953	13,155
Market Capitalization	16,804	18,843	16,105	20,201	24,420	16,801	14,703	14,019	14,258	10,596
Book Value per Share	$2.64	$1.78	$4.52	$3.30	$7.21	$4.39	$5.61	$4.21	$2.30	$0.90
Tangible Book Value per Share	($12.73)	($14.11)	($15.32)	($16.74)	($12.41)	($15.26)	($13.94)	($10.68)	($12.64)	($11.69)
Total Capital	2,977	2,915	3,440	3,376	3,688	3,242	3,987	3,507	3,393	3,059
Total Debt	2,485	2,527	2,711	2,784	2,780	2,683	3,261	2,965	3,096	2,941
Total Long-Term Debt	2,481	2,477	2,474	2,484	2,780	2,287	3,062	2,161	2,573	2,546
Net Debt	2,283	2,160	2,528	2,465	1,909	2,572	3,130	2,547	2,695	2,559
Capital Expenditures (CapEx)	212	228	251	331	254	206	194	231	172	125
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-150	-406	-5.00	-246	-269	150	179	91	49	37
Debt-free Net Working Capital (DFNWC)	52	-39	178	73	602	261	310	509	450	419
Net Working Capital (NWC)	48	-89	-59	-227	602	-135	111	-295	-73	24
Net Nonoperating Expense (NNE)	209	115	111	22	71	80	64	66	53	3,379
Net Nonoperating Obligations (NNO)	2,283	2,160	2,528	2,465	1,909	2,572	3,130	2,547	2,695	2,559
Total Depreciation and Amortization (D&A)	235	236	224	211	180	180	166	163	165	169
Debt-free, Cash-free Net Working Capital to Revenue	-2.11%	-5.49%	-0.07%	-3.35%	-4.00%	2.41%	2.92%	1.52%	0.85%	0.65%
Debt-free Net Working Capital to Revenue	0.73%	-0.53%	2.50%	0.99%	8.96%	4.20%	5.06%	8.52%	7.81%	7.41%
Net Working Capital to Revenue	0.68%	-1.20%	-0.83%	-3.09%	8.96%	-2.17%	1.81%	-4.94%	-1.27%	0.42%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.26	$1.21	$3.75	$5.66	$7.46	$6.42	$0.00	$0.00	$5.01	$4.45
Adjusted Weighted Average Basic Shares Outstanding	124.17M	123.59M	123.11M	125.57M	125.83M	127.73M	0.00	0.00	129.47M	130.31M
Adjusted Diluted Earnings per Share	$2.25	$1.20	$3.73	$5.58	$7.36	$6.32	$0.00	$0.00	$4.92	$4.37
Adjusted Weighted Average Diluted Shares Outstanding	124.80M	124.18M	123.91M	127.30M	127.67M	129.79M	0.00	0.00	131.72M	132.78M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	123.86M	123.83M	123.16M	122.81M	126.21M	125.74M	0.00	0.00	129.47M	128.64M
Normalized Net Operating Profit after Tax (NOPAT)	677	577	582	1,003	1,010	900	887	767	701	3,959
Normalized NOPAT Margin	9.55%	7.81%	8.19%	13.67%	15.02%	14.48%	14.48%	12.84%	12.17%	70.00%
Pre Tax Income Margin	5.61%	3.22%	8.54%	12.26%	17.63%	16.48%	17.21%	17.29%	17.06%	0.00%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.42	3.64	6.73	10.09	12.97	11.56	13.40	12.74	12.17	0.00
NOPAT to Interest Expense	5.57	3.07	5.49	7.48	10.20	9.28	10.44	8.72	7.97	0.00
EBIT Less CapEx to Interest Expense	3.07	1.11	4.36	6.75	10.40	9.43	11.12	10.11	10.22	0.00
NOPAT Less CapEx to Interest Expense	3.21	0.53	3.12	4.14	7.63	7.16	8.15	6.09	6.02	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	209.25%	371.43%	124.42%	81.92%	56.76%	59.76%	54.68%	58.77%	61.42%	66.38%
Augmented Payout Ratio	209.25%	371.43%	129.72%	207.79%	83.17%	140.37%	87.61%	84.88%	100.62%	141.21%

This table displays calculated financial ratios and metrics derived from Clorox's official financial filings.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-8.05%	-15.28%	27.13%	-5.75%	-5.27%	16.04%	-20.34%	12.10%	5.86%	1.42%	-3.65%
EBITDA Growth	773.68%	42.47%	127.03%	10.94%	123.60%	3.79%	-42.78%	43.50%	-157.91%	23.39%	-26.79%
EBIT Growth	1,485.00%	59.88%	296.00%	14.73%	90.95%	5.88%	-63.77%	55.42%	-200.00%	31.90%	-34.29%
NOPAT Growth	1,286.55%	-16.05%	91.62%	17.45%	88.83%	96.84%	-58.57%	47.01%	-178.21%	30.18%	-23.80%
Net Income Growth	482.00%	102.08%	312.00%	22.10%	76.08%	-5.88%	-71.26%	74.04%	-237.50%	41.67%	-39.16%
EPS Growth	465.85%	105.33%	370.59%	21.68%	76.02%	-6.25%	-75.00%	74.39%	-241.32%	42.86%	-40.35%
Operating Cash Flow Growth	57.14%	17.65%	1,005.00%	-20.93%	-46.63%	-26.79%	-88.76%	28.36%	48.91%	15.47%	334.15%
Free Cash Flow Firm Growth	413.75%	-56.99%	-83.48%	-97.00%	-118.39%	134.42%	122.52%	1,864.78%	184.14%	-21.51%	51.84%
Invested Capital Growth	-4.80%	-3.32%	-0.25%	8.91%	3.26%	-13.93%	-19.83%	-21.77%	-20.92%	-5.05%	-5.18%
Revenue Q/Q Growth	-1.07%	-4.31%	-7.41%	4.91%	-8.84%	43.58%	-31.35%	5.43%	11.66%	-1.44%	-3.39%
EBITDA Q/Q Growth	6.41%	23.81%	-29.01%	834.21%	-82.65%	97.30%	-65.31%	298.76%	-176.30%	8.76%	-13.00%
EBIT Q/Q Growth	6.95%	30.81%	-33.11%	1,580.00%	-112.35%	224.00%	-80.62%	216.74%	-244.44%	10.87%	-16.87%
NOPAT Q/Q Growth	-5.41%	88.62%	-59.80%	1,754.24%	-106.69%	330.54%	-75.36%	257.28%	-217.96%	-9.37%	-12.56%
Net Income Q/Q Growth	-1.55%	88.35%	-53.39%	542.00%	-152.08%	284.00%	-86.19%	186.60%	-304.90%	17.24%	-16.35%
EPS Q/Q Growth	-2.60%	92.50%	-54.02%	524.39%	-154.67%	341.18%	-88.11%	183.63%	-313.75%	17.65%	-17.07%
Operating Cash Flow Q/Q Growth	58.89%	-18.55%	-35.00%	86.81%	18.95%	665.00%	-95.35%	26.10%	63.16%	17.42%	-46.87%
Free Cash Flow Firm Q/Q Growth	10.58%	157.50%	290.66%	128.20%	-115.16%	-1.12%	-29.10%	73.03%	93.24%	-6.13%	662.28%
Invested Capital Q/Q Growth	-0.08%	2.92%	-12.36%	5.63%	1.47%	6.19%	-4.32%	0.16%	-15.43%	-1.09%	-6.63%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	44.60%	43.77%	45.80%	46.45%	42.23%	43.52%	38.38%	42.69%	41.78%	36.15%	35.98%
EBITDA Margin	19.90%	18.51%	14.30%	18.65%	2.09%	11.01%	8.01%	15.85%	-8.41%	12.30%	11.15%
Operating Margin	14.57%	14.00%	9.99%	16.66%	-1.21%	16.38%	4.47%	14.07%	-10.29%	8.69%	9.89%
EBIT Margin	16.61%	15.36%	11.24%	15.55%	-1.10%	8.14%	3.61%	12.78%	-11.54%	8.92%	7.93%
Profit (Net Income) Margin	11.45%	11.51%	5.85%	11.61%	-2.76%	4.82%	1.80%	8.96%	-10.91%	5.95%	5.00%
Tax Burden Percent	75.20%	81.86%	58.19%	80.36%	119.05%	70.59%	86.21%	76.37%	85.31%	78.46%	75.00%
Interest Burden Percent	91.70%	91.51%	89.39%	92.91%	210.00%	83.95%	58.00%	91.86%	110.86%	84.97%	84.06%
Effective Tax Rate	24.80%	18.14%	41.81%	19.64%	0.00%	29.41%	13.79%	23.63%	0.00%	21.54%	25.00%
Return on Invested Capital (ROIC)	29.99%	32.25%	17.83%	35.68%	-2.37%	30.21%	9.90%	27.35%	-17.93%	15.60%	16.71%
ROIC Less NNEP Spread (ROIC-NNEP)	30.34%	32.28%	17.86%	34.16%	-3.83%	24.72%	8.73%	25.82%	-20.76%	15.02%	15.10%
Return on Net Nonoperating Assets (RNNOA)	319.31%	452.58%	227.09%	172.46%	-42.50%	170.41%	67.56%	108.35%	-139.16%	79.45%	75.33%
Return on Equity (ROE)	349.30%	484.83%	244.92%	208.13%	-44.87%	200.62%	77.46%	135.70%	-157.08%	95.05%	92.04%
Cash Return on Invested Capital (CROIC)	33.42%	23.46%	22.43%	10.30%	14.39%	25.03%	29.14%	33.94%	30.25%	23.63%	22.67%
Operating Return on Assets (OROA)	20.60%	19.17%	14.61%	18.87%	-1.37%	9.96%	4.18%	15.60%	-13.63%	10.30%	8.99%
Return on Assets (ROA)	14.20%	14.36%	7.60%	14.09%	-3.42%	5.90%	2.09%	10.95%	-12.89%	6.87%	5.67%
Return on Common Equity (ROCE)	92.62%	17.16%	15.87%	129.61%	-9.88%	105.83%	35.70%	94.27%	-84.63%	61.37%	61.24%
Return on Equity Simple (ROE_SIMPLE)	2,625.93%	-1,141.46%	616.67%	0.00%	276.92%	175.47%	-267.57%	0.00%	2,800.00%	138.63%	127.30%
Net Operating Profit after Tax (NOPAT)	183	193	102	255	-15	230	53	217	-138	117	129
NOPAT Margin	10.95%	11.46%	5.81%	13.39%	-0.85%	11.56%	3.86%	10.74%	-7.20%	6.82%	7.41%
Net Nonoperating Expense Percent (NNEP)	-0.35%	-0.03%	-0.03%	1.52%	1.46%	5.49%	1.17%	1.53%	2.84%	0.57%	1.61%
Return On Investment Capital (ROIC_SIMPLE)	6.70%	6.92%	-	-	-	7.82%	-	-	-	-	-
Cost of Revenue to Revenue	55.40%	56.23%	54.20%	53.55%	57.77%	56.48%	61.62%	57.31%	58.22%	63.85%	64.02%
SG&A Expenses to Revenue	16.01%	16.61%	15.95%	14.08%	16.59%	16.18%	19.91%	16.30%	16.24%	16.44%	15.00%
R&D to Revenue	1.62%	1.84%	1.76%	1.73%	1.76%	1.61%	2.09%	1.88%	1.83%	1.92%	1.84%
Operating Expenses to Revenue	30.04%	29.77%	35.81%	29.80%	43.44%	27.14%	33.91%	28.63%	52.06%	27.46%	26.09%
Earnings before Interest and Taxes (EBIT)	277	259	198	296	-20	162	50	258	-221	153	138
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	332	312	252	355	38	219	111	320	-161	211	194
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	666.07	0.00	333.73	51.23	205.33	320.47	0.00	85.65	6,199.72	50.90	45.38
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.56	2.78	2.68	2.37	2.59	2.32	2.21	2.55	2.59	2.31	2.10
Price to Earnings (P/E)	25.91	43.65	56.09	60.01	77.85	212.31	180.79	126.46	251.34	37.56	36.53
Dividend Yield	3.33%	3.00%	2.98%	3.55%	3.17%	3.48%	3.78%	3.10%	3.12%	3.53%	3.88%
Earnings Yield	3.86%	2.29%	1.78%	1.67%	1.28%	0.47%	0.55%	0.79%	0.40%	2.66%	2.74%
Enterprise Value to Invested Capital (EV/IC)	8.18	8.99	9.21	6.94	8.08	7.54	7.39	8.31	8.31	6.33	5.76
Enterprise Value to Revenue (EV/Rev)	2.91	3.14	3.00	2.71	2.94	2.67	2.56	2.87	2.95	2.69	2.49
Enterprise Value to EBITDA (EV/EBITDA)	16.35	23.50	25.92	26.63	30.84	39.92	37.47	37.54	45.27	21.00	20.22
Enterprise Value to EBIT (EV/EBIT)	19.86	30.69	35.21	39.45	47.16	78.40	75.10	64.54	89.58	28.06	27.32
Enterprise Value to NOPAT (EV/NOPAT)	27.99	43.98	41.47	38.42	46.64	69.38	92.25	76.71	106.57	33.40	32.29
Enterprise Value to Operating Cash Flow (EV/OCF)	19.92	24.37	25.00	27.70	27.03	20.68	18.02	18.28	19.89	20.01	18.97
Enterprise Value to Free Cash Flow (EV/FCFF)	23.88	37.65	41.01	70.23	57.05	27.87	22.57	21.49	24.26	26.08	24.72
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	13.35	22.08	11.10	5.05	10.16	12.50	21.56	6.51	15.20	5.47	5.69
Long-Term Debt to Equity	13.07	20.52	11.08	5.04	9.73	11.37	18.92	6.38	14.40	5.04	4.99
Financial Leverage	10.52	14.02	12.72	5.05	11.11	6.89	7.74	4.20	6.70	5.29	4.99
Leverage Ratio	25.43	33.88	32.36	13.29	27.22	16.86	19.37	10.84	16.23	12.46	11.91
Compound Leverage Factor	23.32	31.00	28.93	12.35	57.16	14.15	11.23	9.95	17.99	10.59	10.02
Debt to Total Capital	93.03%	95.67%	91.73%	83.47%	91.04%	92.60%	95.57%	86.69%	93.83%	84.54%	85.06%
Short-Term Debt to Total Capital	1.98%	6.77%	0.15%	0.13%	3.90%	8.39%	11.74%	1.72%	4.95%	6.58%	10.49%
Long-Term Debt to Total Capital	91.05%	88.90%	91.59%	83.34%	87.14%	84.21%	83.83%	84.97%	88.87%	77.96%	74.57%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	5.98%	5.80%	6.05%	5.51%	5.76%	5.60%	5.68%	5.76%	6.07%	5.35%	5.12%
Common Equity to Total Capital	0.99%	-1.47%	2.21%	11.02%	3.20%	1.80%	-1.25%	7.55%	0.11%	10.11%	9.82%
Debt to EBITDA	2.03	2.79	2.88	3.44	3.77	5.57	5.87	4.48	5.60	2.96	3.26
Net Debt to EBITDA	1.85	2.49	2.56	3.16	3.45	4.85	4.80	3.83	5.08	2.78	2.94
Long-Term Debt to EBITDA	1.98	2.59	2.87	3.43	3.60	5.07	5.15	4.39	5.30	2.73	2.86
Debt to NOPAT	3.47	5.22	4.60	4.96	5.69	9.69	14.46	9.16	13.18	4.71	5.21
Net Debt to NOPAT	3.16	4.66	4.09	4.56	5.21	8.43	11.81	7.83	11.96	4.42	4.69
Long-Term Debt to NOPAT	3.40	4.86	4.60	4.95	5.45	8.81	12.68	8.97	12.48	4.35	4.56
Altman Z-Score	3.37	3.63	3.76	3.39	3.22	3.13	2.80	3.54	3.13	3.15	2.93
Noncontrolling Interest Sharing Ratio	73.48%	96.46%	93.52%	37.73%	77.99%	47.25%	53.91%	30.53%	46.12%	35.44%	33.46%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.74	0.94	1.00	1.03	0.90	0.89	0.86	0.95	0.87	0.86	0.88
Quick Ratio	0.38	0.52	0.55	0.57	0.48	0.51	0.49	0.55	0.46	0.41	0.44
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	309	279	108	28	-98	649	656	926	535	277	295
Operating Cash Flow to CapEx	539.62%	339.62%	566.67%	419.75%	330.91%	294.23%	83.33%	511.90%	608.93%	497.62%	386.96%
Free Cash Flow to Firm to Interest Expense	13.42	12.69	5.16	1.32	-4.47	24.97	31.26	44.09	22.30	12.04	13.41
Operating Cash Flow to Interest Expense	12.43	8.18	10.52	16.19	8.27	5.88	0.95	20.48	14.21	9.09	8.09
Operating Cash Flow Less CapEx to Interest Expense	10.13	5.77	8.67	12.33	5.77	3.88	-0.19	16.48	11.88	7.26	6.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.24	1.25	1.30	1.21	1.24	1.22	1.16	1.22	1.18	1.15	1.13
Accounts Receivable Turnover	11.05	11.18	12.70	10.26	10.67	11.43	11.79	10.79	10.72	12.09	11.12
Inventory Turnover	5.88	6.37	6.36	6.07	5.94	6.09	5.76	6.18	5.80	5.78	5.90
Fixed Asset Turnover	5.53	5.61	5.84	5.33	5.53	5.55	5.33	5.52	5.46	5.39	5.37
Accounts Payable Turnover	2.10	2.55	2.63	2.57	2.48	2.63	2.59	2.87	2.70	2.88	2.87
Days Sales Outstanding (DSO)	33.02	32.65	28.73	35.58	34.20	31.93	30.95	33.81	34.05	30.20	32.81
Days Inventory Outstanding (DIO)	62.11	57.32	57.40	60.14	61.47	59.95	63.34	59.10	62.98	63.20	61.91
Days Payable Outstanding (DPO)	174.10	142.92	138.66	141.89	147.25	139.04	141.04	127.40	135.00	126.84	127.27
Cash Conversion Cycle (CCC)	-78.97	-52.94	-52.52	-46.17	-51.57	-47.17	-46.75	-34.49	-37.97	-33.45	-32.55
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,501	2,503	2,432	2,775	2,627	2,589	2,438	2,548	2,544	3,008	3,041
Invested Capital Turnover	2.74	2.81	3.07	2.67	2.79	2.61	2.57	2.55	2.49	2.29	2.25
Increase / (Decrease) in Invested Capital	-126	-86	-6.00	227	83	-419	-603	-709	-673	-160	-166
Enterprise Value (EV)	20,458	22,494	22,396	19,251	21,221	19,521	18,023	21,171	21,140	19,026	17,510
Market Capitalization	17,984	19,950	20,024	16,804	18,685	16,985	15,548	18,843	18,599	16,339	14,795
Book Value per Share	$0.22	($0.33)	$0.48	$2.64	$0.73	$0.43	($0.30)	$1.78	$0.02	$2.60	$2.65
Tangible Book Value per Share	($14.32)	($14.82)	($14.16)	($12.73)	($14.71)	($15.29)	($16.04)	($14.11)	($15.94)	($17.02)	($17.01)
Total Capital	2,727	2,793	2,710	2,977	2,846	2,944	2,956	2,915	2,786	3,176	3,319
Total Debt	2,537	2,672	2,486	2,485	2,591	2,726	2,825	2,527	2,614	2,685	2,823
Total Long-Term Debt	2,483	2,483	2,482	2,481	2,480	2,479	2,478	2,477	2,476	2,476	2,475
Net Debt	2,311	2,382	2,208	2,283	2,372	2,371	2,307	2,160	2,372	2,517	2,545
Capital Expenditures (CapEx)	53	53	39	81	55	52	24	84	56	42	46
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-737	-199	-277	-150	-293	-326	-488	-406	-355	-215	-177
Debt-free Net Working Capital (DFNWC)	-511	91	1.00	52	-74	29	30	-39	-113	-47	101
Net Working Capital (NWC)	-565	-98	-3.00	48	-185	-218	-317	-89	-251	-256	-247
Net Nonoperating Expense (NNE)	-8.27	-0.82	-0.58	34	35	134	28	36	71	15	42
Net Nonoperating Obligations (NNO)	2,311	2,382	2,208	2,283	2,372	2,371	2,307	2,160	2,372	2,517	2,545
Total Depreciation and Amortization (D&A)	55	53	54	59	58	57	61	62	60	58	56
Debt-free, Cash-free Net Working Capital to Revenue	-10.50%	-2.78%	-3.71%	-2.11%	-4.06%	-4.46%	-6.94%	-5.49%	-4.95%	-3.04%	-2.51%
Debt-free Net Working Capital to Revenue	-7.28%	1.27%	0.01%	0.73%	-1.03%	0.40%	0.43%	-0.53%	-1.58%	-0.67%	1.43%
Net Working Capital to Revenue	-8.05%	-1.37%	-0.04%	0.68%	-2.57%	-2.98%	-4.51%	-1.20%	-3.50%	-3.62%	-3.51%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.51	$1.55	$0.80	$1.75	($0.41)	$0.75	$0.17	$1.42	($1.71)	$0.81	$0.69
Adjusted Weighted Average Basic Shares Outstanding	123.37M	123.77M	123.80M	124.17M	124.25M	124.18M	123.97M	123.59M	123.65M	123.55M	123.34M
Adjusted Diluted Earnings per Share	$1.50	$1.54	$0.80	$1.74	($0.41)	$0.75	$0.17	$1.43	($1.71)	$0.80	$0.68
Adjusted Weighted Average Diluted Shares Outstanding	124.07M	124.66M	124.68M	124.80M	124.25M	124.62M	124.65M	124.18M	123.65M	123.99M	123.91M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	123.25M	123.19M	123.78M	123.86M	124.19M	124.11M	124.06M	123.83M	123.62M	123.52M	123.38M
Normalized Net Operating Profit after Tax (NOPAT)	183	193	171	255	153	230	53	217	174	117	129
Normalized NOPAT Margin	10.95%	11.46%	9.71%	13.39%	8.41%	11.56%	3.86%	10.74%	9.07%	6.82%	7.41%
Pre Tax Income Margin	15.23%	14.06%	10.05%	14.45%	-2.32%	6.83%	2.09%	11.74%	-12.79%	7.58%	6.67%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	12.04	11.77	9.43	14.10	-0.91	6.23	2.38	12.29	-9.21	6.65	6.27
NOPAT to Interest Expense	7.94	8.78	4.88	12.13	-0.70	8.85	2.55	10.33	-5.75	5.08	5.86
EBIT Less CapEx to Interest Expense	9.74	9.36	7.57	10.24	-3.41	4.23	1.24	8.29	-11.54	4.83	4.18
NOPAT Less CapEx to Interest Expense	5.64	6.37	3.02	8.27	-3.20	6.85	1.40	6.33	-8.08	3.26	3.77
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	89.28%	131.41%	165.68%	209.25%	240.87%	650.54%	608.08%	371.43%	702.38%	131.91%	141.93%
Augmented Payout Ratio	125.53%	186.32%	194.59%	209.25%	240.87%	650.54%	608.08%	371.43%	702.38%	131.91%	141.93%

Frequently Asked Questions About Clorox's Financials

When does Clorox's fiscal year end?

According to the most recent income statement we have on file, Clorox's financial year ends in June. Their financial year 2024 ended on June 30, 2024.

How has Clorox's net income changed over the last 9 years?

Clorox's net income appears to be on a downward trend, with a most recent value of $292 million in 2024, falling from $580 million in 2015. The previous period was $161 million in 2023. See Clorox's forecast for analyst expectations on what’s next for the company.

What is Clorox's operating income?

Clorox's total operating income in 2024 was $683 million, based on the following breakdown:

Total Gross Profit: $3.05 billion
Total Operating Expenses: $2.37 billion

How has Clorox revenue changed over the last 9 years?

Over the last 9 years, Clorox's total revenue changed from $5.66 billion in 2015 to $7.09 billion in 2024, a change of 25.4%.

How much debt does Clorox have?

Clorox's total liabilities were at $5.26 billion at the end of 2024, a 5.4% decrease from 2023, and a 30.0% increase since 2015.

How much cash does Clorox have?

In the past 9 years, Clorox's cash and equivalents has ranged from $111 million in 2019 to $871 million in 2020, and is currently $202 million as of their latest financial filing in 2024.

How has Clorox's book value per share changed over the last 9 years?

Over the last 9 years, Clorox's book value per share changed from 0.90 in 2015 to 2.64 in 2024, a change of 193.6%.

Related Companies

This page (NYSE:CLX) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Clorox (CLX) Financials

Frequently Asked Questions About Clorox's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Clorox (CLX) Financials

Annual Income Statements for Clorox

Quarterly Income Statements for Clorox

Annual Cash Flow Statements for Clorox

Quarterly Cash Flow Statements for Clorox

Annual Balance Sheets for Clorox

Quarterly Balance Sheets for Clorox

Annual Metrics And Ratios for Clorox

Quarterly Metrics And Ratios for Clorox

Frequently Asked Questions About Clorox's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools